Kyle W. Keese

2010

In 2010, Kyle W. Keese earned a total compensation of $788.4K as Executive Vice President, Biosciences Division at Emergent BioSolutions, a 22% increase compared to previous year.

Compensation breakdown

Bonus$185,900
Option Awards$120,804
Salary$335,434
Stock Awards$138,958
Other$7,350
Total$788,445

Keese received $335.4K in salary, accounting for 43% of the total pay in 2010.

Keese also received $185.9K in bonus, $120.8K in option awards, $139K in stock awards and $7.4K in other compensation.

Rankings

In 2010, Kyle W. Keese's compensation ranked 6,170th out of 10,439 executives tracked by ExecPay. In other words, Keese earned more than 40.9% of executives.

ClassificationRankingPercentile
All
6,170
out of 10,439
41st
Division
Manufacturing
2,218
out of 3,838
42nd
Major group
Chemicals And Allied Products
488
out of 921
47th
Industry group
Drugs
304
out of 680
55th
Industry
Pharmaceutical Preparations
227
out of 481
53rd
Source: SEC filing on April 6, 2012.

Keese's colleagues

We found four more compensation records of executives who worked with Kyle W. Keese at Emergent BioSolutions in 2010.

2010

Fuad El-Hibri

Emergent BioSolutions

Chairman

2010

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

2010

R Elsey

Emergent BioSolutions

Chief Financial Officer

2010

Stephen Lockhart

Emergent BioSolutions

Senior Vice President, Product Development

You may also like